Valcyte | Valganciclovir Tablet while Breastfeeding
It is a well known fact that breastfeeding is best source of nutrition for infants. Breast milk provides minerals, vitamins and antibodies in most acceptable format when they need it. Nutrition taken by mother passes to breast-milk and same thing applies to medicines taken by mothers. Not all drugs cause problem for baby but some do. Lets analyze if Valcyte | Valganciclovir Tablet is safe for baby while breastfed.

What is Valcyte | Valganciclovir Tablet used for?


VALCYTE is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for: Adult Patients (1.1) Treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). Prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at high risk. Pediatric Patients (1.2) Prevention of CMV disease in kidney and heart transplant patients at high risk. 1.1 Adult Patients Treatment of Cytomegalovirus (CMV) Retinitis: VALCYTE is indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) [see Clinical Studies (14.1)]. Prevention of CMV Disease: VALCYTE is indicated for the prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at high risk (Donor CMV seropositive/Recipient CMV seronegative [D+/R-]) [see Clinical Studies (14.1)]. 1.2 Pediatric Patients Prevention of CMV Disease: VALCYTE is indicated for the prevention of CMV disease in kidney transplant patients (4 months to 16 years of age) and heart transplant patients (1 month to 16 years of age) at high risk [see Clinical Studies (14.2)].

Valcyte | Valganciclovir Tablet while breastfeeding safe or not? Can there be any side effects for infant while using it during breastfeeding?

Valcyte | Valganciclovir Tablet low risk for breastfeeding
Valcyte | Valganciclovir Tablet contains only one active ingredient that is Valganciclovir. We have analyzed the usage of Valganciclovir in breastfeeding and our analysis suggest that Valganciclovir poses Low risk for infant while breastfeeding and hence Valcyte | Valganciclovir Tablet itself shall be considered Low risk item for breastfeeding.

Valcyte | Valganciclovir Tablet Breastfeeding Analsys


Valganciclovir while Breastfeeding

Low Risk

CAS Number: 175865-60-8

Ganciclovir-related drug which is absorbable by mouth. It is indicated for treatment of retinitis caused by Citomegalovirus.

Valcyte | Valganciclovir Tablet Breastfeeding Analsys - 2


Valganciclovir while Breastfeeding

CAS Number: 175865-60-8

Valganciclovir is rapidly converted to ganciclovir. Several factors might affect the decision to use valganciclovir in a nursing mother. No information is available on the clinical use of ganciclovir or valganciclovir during breastfeeding. Cytomegalovirus (CMV) can be transmitted to infants though breastmilk, with preterm and immunocompromised infants at greatest risk. No information is available on any changes in the risk of transmission if the mother is being treated with ganciclovir or valganciclovir. Although the manufacturer recommends avoiding breastfeeding during valganciclovir use because of the risk of infant drug toxicity, neonates with CMV infections are often treated directly with ganciclovir or valganciclovir. If the mother has a concurrent infection with HIV, breastfeeding is not recommended in the United States and other developed countries.

Is Valcyte | Valganciclovir Tablet safe while breastfeeding

What should I do if already breastfed my kid after using Valcyte | Valganciclovir Tablet?

During whole lactation period you shall first discuss with your doctor and then together you shall decide whether you shall take that drug or not however if you have already taken Valcyte | Valganciclovir Tablet then you shall inform your doctor, But you should not be worried too much as Valcyte | Valganciclovir Tablet comes in category of low risk drug.


I am nursing mother and my doctor has suggested me to use Valcyte | Valganciclovir Tablet, is it safe?

Though Valcyte | Valganciclovir Tablet dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Valcyte | Valganciclovir Tablet, will my baby need extra monitoring?

Not much


Who can I talk to if I have questions about usage of Valcyte | Valganciclovir Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Valganciclovir Tablet
Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution
Valcyte | Valganciclovir Tablet